Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus

Background: Chronic immunosuppressive treatment with cyclosporine A (CsA) leads to multiple side effects, including some that occur in the central nervous system (CNS). This study aims to investigate the impact of long-term CsA treatment on anxiety behavior and verify the alterations related to glut...

Full description

Bibliographic Details
Main Authors: Marina Minto Cararo-Lopes, Débora Guerini Souza, Marcelo Ganzella, Gisele Hansel, Vanessa Kazlauckas, Paloma Segura De Mello, Larissa De Sá Lima, Elisa Mitiko Kawamoto, Luis Valmor Portela, Diogo Onofre Souza, Cristoforo Scavone, Ana Elisa Böhmer
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Affective Disorders Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666915322000865
_version_ 1811207771458109440
author Marina Minto Cararo-Lopes
Débora Guerini Souza
Marcelo Ganzella
Gisele Hansel
Vanessa Kazlauckas
Paloma Segura De Mello
Larissa De Sá Lima
Elisa Mitiko Kawamoto
Luis Valmor Portela
Diogo Onofre Souza
Cristoforo Scavone
Ana Elisa Böhmer
author_facet Marina Minto Cararo-Lopes
Débora Guerini Souza
Marcelo Ganzella
Gisele Hansel
Vanessa Kazlauckas
Paloma Segura De Mello
Larissa De Sá Lima
Elisa Mitiko Kawamoto
Luis Valmor Portela
Diogo Onofre Souza
Cristoforo Scavone
Ana Elisa Böhmer
author_sort Marina Minto Cararo-Lopes
collection DOAJ
description Background: Chronic immunosuppressive treatment with cyclosporine A (CsA) leads to multiple side effects, including some that occur in the central nervous system (CNS). This study aims to investigate the impact of long-term CsA treatment on anxiety behavior and verify the alterations related to glutamate signaling in the rat hippocampus. Methods: Adult male Wistar rats were intraperitoneally injected with 15 mg/kg/day CsA for eight weeks, subjected to anxiety tests, and had their brains collected for biochemistry and Western blot analysis. Results: Herein, we reported that eight weeks of CsA treatment promoted an anxiety-like effect and increased N-methyl-D-aspartate receptor (NMDAR) GluN2 subunit levels, nitric oxide synthase, and cAMP-response element binding protein (CREB) activities. Limitations: Future work should consider the impact of long-term CsA treatment on NMDAR function, as well as on other neurotransmitter signaling pathways. Peripheral side effects should also be considered a factor that could lead to CsA-induced neuropsychiatric effects. Conclusions: In conclusion, this work reports modifications to CNS adaptive responses following chronic CsA treatment, which can influence anxiogenic behavior and other associated neurotoxic events. Understanding the mechanisms underlying CsA-induced neuropsychiatric side effects is an important step toward better symptom management in patients submitted to immunosuppression in the clinical setting.
first_indexed 2024-04-12T04:10:26Z
format Article
id doaj.art-f99023825e4d4fe69ee5ec7611242149
institution Directory Open Access Journal
issn 2666-9153
language English
last_indexed 2024-04-12T04:10:26Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Journal of Affective Disorders Reports
spelling doaj.art-f99023825e4d4fe69ee5ec76112421492022-12-22T03:48:31ZengElsevierJournal of Affective Disorders Reports2666-91532022-12-0110100394Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampusMarina Minto Cararo-Lopes0Débora Guerini Souza1Marcelo Ganzella2Gisele Hansel3Vanessa Kazlauckas4Paloma Segura De Mello5Larissa De Sá Lima6Elisa Mitiko Kawamoto7Luis Valmor Portela8Diogo Onofre Souza9Cristoforo Scavone10Ana Elisa Böhmer11Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes, 1524, São Paulo 05508-900, Brazil; Corresponding author.Department of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, BrazilNeurobiology Department, Max Planck Institute for Biophysical Chemistry, Göttingen, GermanyDepartment of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, BrazilDepartment of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, BrazilDepartment of Pharmacology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes, 1524, São Paulo 05508-900, BrazilDepartment of Pharmacology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes, 1524, São Paulo 05508-900, BrazilDepartment of Pharmacology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes, 1524, São Paulo 05508-900, BrazilDepartment of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, BrazilDepartment of Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, BrazilDepartment of Pharmacology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes, 1524, São Paulo 05508-900, BrazilDepartment of Pharmacology, Institute of Biomedical Science, University of São Paulo, Avenida Professor Lineu Prestes, 1524, São Paulo 05508-900, BrazilBackground: Chronic immunosuppressive treatment with cyclosporine A (CsA) leads to multiple side effects, including some that occur in the central nervous system (CNS). This study aims to investigate the impact of long-term CsA treatment on anxiety behavior and verify the alterations related to glutamate signaling in the rat hippocampus. Methods: Adult male Wistar rats were intraperitoneally injected with 15 mg/kg/day CsA for eight weeks, subjected to anxiety tests, and had their brains collected for biochemistry and Western blot analysis. Results: Herein, we reported that eight weeks of CsA treatment promoted an anxiety-like effect and increased N-methyl-D-aspartate receptor (NMDAR) GluN2 subunit levels, nitric oxide synthase, and cAMP-response element binding protein (CREB) activities. Limitations: Future work should consider the impact of long-term CsA treatment on NMDAR function, as well as on other neurotransmitter signaling pathways. Peripheral side effects should also be considered a factor that could lead to CsA-induced neuropsychiatric effects. Conclusions: In conclusion, this work reports modifications to CNS adaptive responses following chronic CsA treatment, which can influence anxiogenic behavior and other associated neurotoxic events. Understanding the mechanisms underlying CsA-induced neuropsychiatric side effects is an important step toward better symptom management in patients submitted to immunosuppression in the clinical setting.http://www.sciencedirect.com/science/article/pii/S2666915322000865CyclosporineAnxietyGlutamateN-methyl-D-aspartate receptorsCREBNitric oxide synthase
spellingShingle Marina Minto Cararo-Lopes
Débora Guerini Souza
Marcelo Ganzella
Gisele Hansel
Vanessa Kazlauckas
Paloma Segura De Mello
Larissa De Sá Lima
Elisa Mitiko Kawamoto
Luis Valmor Portela
Diogo Onofre Souza
Cristoforo Scavone
Ana Elisa Böhmer
Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus
Journal of Affective Disorders Reports
Cyclosporine
Anxiety
Glutamate
N-methyl-D-aspartate receptors
CREB
Nitric oxide synthase
title Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus
title_full Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus
title_fullStr Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus
title_full_unstemmed Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus
title_short Long-term cyclosporine A treatment promotes anxiety-like behavior: Possible relation with glutamate signaling in rat hippocampus
title_sort long term cyclosporine a treatment promotes anxiety like behavior possible relation with glutamate signaling in rat hippocampus
topic Cyclosporine
Anxiety
Glutamate
N-methyl-D-aspartate receptors
CREB
Nitric oxide synthase
url http://www.sciencedirect.com/science/article/pii/S2666915322000865
work_keys_str_mv AT marinamintocararolopes longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT deboraguerinisouza longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT marceloganzella longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT giselehansel longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT vanessakazlauckas longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT palomasegurademello longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT larissadesalima longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT elisamitikokawamoto longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT luisvalmorportela longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT diogoonofresouza longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT cristoforoscavone longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus
AT anaelisabohmer longtermcyclosporineatreatmentpromotesanxietylikebehaviorpossiblerelationwithglutamatesignalinginrathippocampus